Efficacy of N-acetylcysteine and all-trans retinoic acid in restoring in vitro effective hemopoiesis in myelodysplastic syndromes

Agostino Cortelezzi(Istituti di Ricovero e Cura a Carattere Scientifico), Anna Teresa Maiolo(Policlinico San Matteo Fondazione), G Gornati(Istituti Clinici di Perfezionamento), Ilaria Silvestris(University of Milan), Chiara Cattaneo(Humanitas University), Marina Motta(Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia), Barbara Sarina(IRCCS Humanitas Research Hospital), Adalberto Ibatici(Ospedale Policlinico San Martino), Aldo Della Volpe(Ospedale Maggiore), Silvia Cristiani(University of Milan), Mauro Pomati(University of Milan)
Leukemia Research
February 1, 2000
10.1016/s0145-2126(99)00165-4
Cited by 10

Related Papers

Clinical characteristics and risk factors associated with COVID-19 severity in patients with haematological malignancies in Italy: a retrospective, multicentre, cohort study
|The Lancet Haematology|2020|553
Improved risk classification for risk-specific therapy based on the molecular study of minimal residual disease (MRD) in adult acute lymphoblastic leukemia (ALL)
|Blood|2009|433
Improved Outcomes With Retinoic Acid and Arsenic Trioxide Compared With Retinoic Acid and Chemotherapy in Non–High-Risk Acute Promyelocytic Leukemia: Final Results of the Randomized Italian-German APL0406 Trial
|Journal of Clinical Oncology|2016|394
Clinical heterogeneity and predictors of outcome in primary autoimmune hemolytic anemia: a GIMEMA study of 308 patients
|Blood|2014|373
Invasive aspergillosis in patients with acute myeloid leukemia: a SEIFEM-2008 registry study
|Haematologica|2009|309